Skip to main navigation Skip to search Skip to main content

Perspective: An overemphasis on vaccines for Mpox skewes important lessons from COVID-19 and the need for public health approaches

  • Garrett W. Brown
  • , Jean von Agris
  • , David Bell
  • , Joachim Sturmberg
  • , Valéry Ridde
  • , Samuel Lwamushi Makali
  • , Ghislain Bisimwa Balaluka
  • , Gemma Bridge
  • , Elisabeth Paul

Research output: Contribution to journal › Review article › peer-review

3 Citations (Scopus)
4 Downloads (Pure)

Abstract

The emergency declarations for Mpox triggered a flurry of appeals for ‘vaccine equity’ and the mass production of additional vaccine doses, citing a need to ‘learn lessons’ from COVID-19. We question whether the right lessons have been learned in terms of a supposed need to rollout vaccines quickly and widely, raising concerns about the consequences of an overreliance on expert-driven mass vaccination strategies over more diversified, context-specific and systemic public health strategies. Compared to COVID-19, Mpox has no such epidemic potential because it requires close contact for transmission. Moreover, Congolese populations face far more pressing health burdens. Thus, the health needs of the population risk being lost within a response focused on global procurement of costly health technologies whatever the context in which the outbreak is occurring. Alternatively, locally owned prioritisation and public health and sanitation approaches are key, which should be proportionate to relative disease burdens, and which utilise a diversity of strategies that are cost-effective and with wider public health benefits.
Original languageEnglish
Article number102749
JournalJournal of Infection and Public Health
Volume18
Issue number6
Early online date12 Mar 2025
DOIs
Publication statusPublished - Jun 2025

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Cite this